Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Stojanovic

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Nature Immunology|June 20, 2018
Checkpoint inhibition: NK cells enter the sceneAna Stojanovic, Adelheid Cerwenka
Immunity|October 13, 2021
ILC1-like NK cells as matchmakers for DC-T cell interactionsAna Stojanovic, Adelheid Cerwenka
Cancer Cell|August 27, 2021
An intimate encounter: DC3s empower anti-tumor CTLsAna Stojanovic, Adelheid Cerwenka
Journal of Innate Immunity|April 20, 2011
Natural killer cells and solid tumorsAna Stojanovic, Adelheid Cerwenka
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 18, 2012
Shaping of NK cell responses by the tumor microenvironmentAna Stojanovic, Margareta P Correia, Adelheid Cerwenka
Frontiers in Immunology|May 10, 2018
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and DiseaseAna Stojanovic, Margareta P Correia, Adelheid Cerwenka
Oncoimmunology|June 5, 2013
Toward the next generation of NK cell-based adoptive cancer immunotherapyJing Ni, Matthias Miller, Ana Stojanovic, et al.
Frontiers in Immunology|June 7, 2023
Editorial: ILC checkpoints: expression and functions in physiological and pathological conditionsFrancesca Romana Mariotti, Nadia Guerra, Ana Stojanovic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2014
CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cellsAna Stojanovic, Nathalie Fiegler, Monika Brunner-Weinzierl, et al.
Oncoimmunology|January 17, 2022
Innate-like NKp30<sup>+</sup>CD8<sup>+</sup> T cells armed with TCR/CAR target tumor heterogeneityMargareta P Correia, Ana Stojanovic, Winfried S Wels, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nature Immunology|June 20, 2018
Checkpoint inhibition: NK cells enter the sceneAna Stojanovic, Adelheid Cerwenka
Immunity|October 13, 2021
ILC1-like NK cells as matchmakers for DC-T cell interactionsAna Stojanovic, Adelheid Cerwenka
Cancer Cell|August 27, 2021
An intimate encounter: DC3s empower anti-tumor CTLsAna Stojanovic, Adelheid Cerwenka
Journal of Innate Immunity|April 20, 2011
Natural killer cells and solid tumorsAna Stojanovic, Adelheid Cerwenka
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 18, 2012
Shaping of NK cell responses by the tumor microenvironmentAna Stojanovic, Margareta P Correia, Adelheid Cerwenka
Frontiers in Immunology|May 10, 2018
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and DiseaseAna Stojanovic, Margareta P Correia, Adelheid Cerwenka
Oncoimmunology|June 5, 2013
Toward the next generation of NK cell-based adoptive cancer immunotherapyJing Ni, Matthias Miller, Ana Stojanovic, et al.
Frontiers in Immunology|June 7, 2023
Editorial: ILC checkpoints: expression and functions in physiological and pathological conditionsFrancesca Romana Mariotti, Nadia Guerra, Ana Stojanovic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2014
CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cellsAna Stojanovic, Nathalie Fiegler, Monika Brunner-Weinzierl, et al.
Oncoimmunology|January 17, 2022
Innate-like NKp30<sup>+</sup>CD8<sup>+</sup> T cells armed with TCR/CAR target tumor heterogeneityMargareta P Correia, Ana Stojanovic, Winfried S Wels, et al.
Pageof 4